Company Overview

Medicine Man Technologies, Inc., operating under the trade name Schwazze, is a vertically integrated cannabis company focused on cultivation, manufacturing, distribution, and retail operations in the regulated U.S. cannabis industry. The company operates primarily in the cannabis retail, cultivation, and consumer packaged goods segments, with activities concentrated in limited-license cannabis markets. Its core revenue drivers include dispensary sales, wholesale cannabis products, and branded consumer products sold through owned retail channels and third-party dispensaries. Schwazze has historically emphasized scale through acquisitions and operational integration, particularly in Colorado and New Mexico.

The company was founded in 2014 and was originally focused on cannabis consulting and compliance services before transitioning into direct plant-touching operations through acquisitions and vertical integration. Over time, Medicine Man Technologies expanded from an advisory-oriented business into a multi-state operator with cultivation facilities, manufacturing assets, and retail dispensaries. The company rebranded publicly as Schwazze to reflect its broader operational strategy and consumer-facing identity while retaining the legal corporate name Medicine Man Technologies, Inc. in public filings.

Business Operations

Schwazze generates revenue through vertically integrated cannabis operations spanning cultivation, processing, manufacturing, and retail dispensaries. Its principal operating activities include indoor and greenhouse cultivation, extraction and manufacturing of cannabis products, and direct-to-consumer retail sales through owned dispensary networks. The company operates several cannabis brands and retail banners, including Star Buds, Emerald Fields, and other acquired regional dispensary chains. Revenue is primarily derived from retail cannabis sales, with additional contributions from wholesale distribution and branded product manufacturing.

The company’s operations are concentrated in the U.S., particularly in Colorado and New Mexico, where it maintains cultivation facilities, manufacturing infrastructure, and retail storefronts. Schwazze has expanded largely through acquisitions of dispensary operators and cannabis asset portfolios. Major acquisitions have included Star Buds, Emerald Fields, and multiple regional operators that strengthened its retail footprint and cultivation capacity. The company controls cultivation and manufacturing assets intended to support vertical integration efficiencies, supply-chain control, and margin optimization within regulated state markets.

Strategic Position & Investments

Schwazze’s strategy has centered on consolidating fragmented cannabis markets through acquisitions and operational integration in states with limited licensing frameworks. The company has pursued growth through targeted investments in cultivation expansion, retail density, and manufacturing capabilities intended to support branded product development. Management has emphasized operational efficiency, scale economics, and regional market leadership as key strategic priorities. The company has also invested in data-driven retail operations and customer loyalty initiatives designed to improve consumer retention and product mix optimization.

A substantial portion of the company’s historical expansion has come from acquisitions financed through debt, equity issuances, and structured financing arrangements. Schwazze has integrated several acquired cannabis operators into its platform to create vertically aligned operations across cultivation, manufacturing, and retail. The company has also maintained exposure to emerging cannabis product categories, including concentrates, edibles, and derivative products, although its operations remain concentrated within state-regulated U.S. cannabis markets rather than international expansion initiatives.

Geographic Footprint

Medicine Man Technologies operates primarily within the United States, with its largest operational presence in Colorado and New Mexico. Corporate headquarters are located in Colorado, where the company established its early operations and developed a significant retail and cultivation footprint. Through acquisitions and organic expansion, Schwazze built a network of dispensaries and production facilities intended to create regional market scale in the southwestern United States.

The company does not maintain a significant international operating footprint based on publicly available disclosures. Its activities remain focused on U.S. state-regulated cannabis markets due to ongoing federal cannabis restrictions in the United States and differing international regulatory frameworks. Schwazze’s operational influence is therefore concentrated domestically, particularly in limited-license jurisdictions where management believes scale and vertical integration can provide competitive advantages.

Leadership & Governance

Medicine Man Technologies has evolved from a cannabis consulting business into a vertically integrated operator under a leadership team focused on acquisitions, operational integration, and regional expansion. The company’s governance structure includes executives with backgrounds in finance, operations, retail, and regulated industries. Public filings and investor materials emphasize disciplined capital allocation, operational efficiency, and market consolidation as central components of management’s strategic vision.

Key executives include:

• Justin Dye – Chief Executive Officer
• Nancy Huber – Chief Financial Officer
• Adam Ribner – President
• Krishna Vemuri – Chief Operating Officer
• Scott Kenyon – General Counsel and Corporate Secretary

The company was co-founded by individuals associated with the original Medicine Man cannabis business in Colorado, including industry participants connected to cannabis cultivation and consulting operations. Leadership communications in public filings and investor presentations have consistently highlighted vertical integration, disciplined acquisitions, and operational standardization as core governance and strategic priorities.